MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases. - Wikidata - awgldk - TriplyDB

MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.

MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.

http://www.wikidata.org/entity/Q36598509

about

High-resolution, in vivo magnetic resonance imaging of Drosophila at 18.8 Tesla.A review of MR spectroscopy studies of pediatric bipolar disorder The use of magnetic resonance spectroscopy and magnetic resonance imaging in alcohol research.Glutamate and glutamine: a review of in vivo MRS in the human brain The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.Tissue-specific toxicological effects of cadmium in green mussels (Perna viridis): nuclear magnetic resonance-based metabolomics study.Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder Absolute quantitation of brain metabolites with respect to heterogeneous tissue compositions in (1)H-MR spectroscopic volumes.Developmental risk I: depression and the developing brain.γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers.N-acetylaspartate normalization in bipolar depression after lamotrigine treatment How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients.Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients.In Vivo Detection of CPP-115 Target Engagement in Human Brain.Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders.Hippocampus Glutamate and N-Acetyl Aspartate Markers of Excitotoxic Neuronal Compromise in Posttraumatic Stress Disorder.9.4 T small animal MRI using clinical components for direct translational studies.Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia Two-Dimensional Proton Magnetic Resonance Spectroscopy versus J-Editing for GABA Quantification in Human Brain: Insights from a GABA-Aminotransferase Inhibitor Study

P2860

Q24288731-5CF82FFB-587A-4153-BF84-0223A1BC7FC9 Q26991430-D8879B17-0095-4E44-B885-053D737DA234 Q30616458-C4ECE835-E9AD-430E-AD79-29DB7338DCC6 Q30677120-83B8F2EB-ECDD-45E4-B24E-6FDAF01810C1 Q30987811-B3AACE35-2FFF-4D3F-B20F-87AFB6CF9E15 Q31141746-F8257B35-58EA-4C47-B16B-CC15734C4B95 Q33536778-4F2CF4ED-20F6-4427-A5A0-B91F8E0DE038 Q33780075-F8FCBF67-7DE2-4B2C-AD44-30133DC9628C Q33783427-808F499D-217D-4FD6-8358-611563DAF6D9 Q34172576-AEF6580F-4C49-400E-84FB-3B4C0517ECFB Q34248599-53B33E5A-7FAC-4259-B9F8-3F3094BF6470 Q36295861-A8312FAE-199E-4E08-9914-56798CD02EF0 Q36306253-C89E3887-3296-4317-80A7-DB60E9A25533 Q36460012-A8766A08-BB2B-443A-9863-FE8C0665109F Q36908416-9F6F1B1B-57A5-4F69-A015-4AE77C063BF2 Q38351399-3A691499-AF06-47EF-9FBB-5CA960FFDF59 Q38662848-12B58F81-68D7-41F9-85CB-86CB9CB5580A Q38691885-7471D912-5AE8-4E77-B6D3-3F436B063243 Q47969952-9E4C18B2-5293-4663-BB5E-912F3973832F Q48341059-5316ABBC-AC8C-46F6-B0C1-FC64D7140E19 Q58756272-6F0E5029-C2BD-4D4B-8546-5821E947212E Q58765360-54D93406-443C-4326-8CBB-06FF0D7276B6

P2860

MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.

http://www.wikidata.org/entity/Q36598509

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

MR spectroscopy: its potential ...... tment of psychiatric diseases.

@ast

MR spectroscopy: its potential ...... tment of psychiatric diseases.

@en

type

label

MR spectroscopy: its potential ...... tment of psychiatric diseases.

@ast

MR spectroscopy: its potential ...... tment of psychiatric diseases.

@en

prefLabel

MR spectroscopy: its potential ...... tment of psychiatric diseases.

@ast

MR spectroscopy: its potential ...... tment of psychiatric diseases.

@en

P1433

Q36598509-A0D5800A-28D9-4FEE-85A0-F6BA4B4D61B2

P1476

Q36598509-878C0E49-CC4B-459C-8288-EAB5F70785C8

P2093

Q36598509-6D898822-1F48-42E0-835C-F7E9D2369FF0

Q36598509-FE3431C0-BD3D-45E3-8C44-A6F39FDD0A05

P2860

Q36598509-14E79536-6E2E-44A6-83F6-7F56BADF952A

Q36598509-24EF3B4F-C4D7-4B38-BA20-3451C043E8FB

Q36598509-26B401A9-FBF3-4C6B-BB35-FA488AD771F1

Q36598509-3A442B76-E7EA-4AE4-886E-CE7B5DE19463

Q36598509-4263DC11-8272-4274-8684-7C73B34C229D

Q36598509-4BA74E7A-C675-48EC-8ABC-586B0DC44D7E

Q36598509-4E669B3B-03F8-4EDA-BFF2-BF032B2DD1AA

Q36598509-5A4B295D-8649-4330-A33A-0DC6380C66A0

Q36598509-83410EF0-A2AC-4657-BEEC-DF1DB3A26C7F

Q36598509-99A3343B-6A2B-41AC-9C82-57CD453068D4

P304

Q36598509-3C324BEA-4E2D-4C67-8538-6930A9E4829B

P31

Q36598509-C49BE9BD-978D-463B-B450-0435398566CC

P356

Q36598509-454C7E3E-5D4E-4ABA-B836-EC64A59148B1

P433

Q36598509-F930C431-3A13-4F38-B1FE-FD05B0AB2E1D

P478

Q36598509-235CD02F-F7C2-4B32-8A5F-D627BE592873

P577

Q36598509-FB4999FD-F511-4A40-80D9-4D47219368EC

P5875

Q36598509-DF554A0B-72C0-45EE-801C-5DFE0627FFCD

P698

Q36598509-9E782432-AE48-40C5-985A-D6CD4846BF5F

P356

P1433

NMR in Biomedicine

P1476

MR spectroscopy: its potential ...... tment of psychiatric diseases.

@en

P2093

Graeme F Mason

http://www.w3.org/2001/XMLSchema#string

John H Krystal

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist.

Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients.

Human brain fluoxetine concentrations.

Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration.

NMR determination of the TCA cycle rate and alpha-ketoglutarate/glutamate exchange rate in rat brain.

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.

Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study.

P304

690-701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NBM.1080

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6808570

http://www.w3.org/2001/XMLSchema#string

P698

16986118

http://www.w3.org/2001/XMLSchema#string